Literature DB >> 25696621

Drug-eluting stents for all patients.

A T L Ong, W J van der Giessen.   

Abstract

Entities:  

Year:  2006        PMID： 25696621      PMCID： PMC2557239     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  7 in total

1.  Healing Achilles--sirolimus versus paclitaxel.

Authors:  David J Moliterno
Journal:  N Engl J Med       Date:  2005-08-16       Impact factor: 91.245

2.  Late angiographic stent thrombosis (LAST) events with drug-eluting stents.

Authors:  Andrew T L Ong; Eugène P McFadden; Evelyn Regar; Peter P T de Jaegere; Ron T van Domburg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

3.  Mixed adherence to clinical practice guidelines for colorectal cancer in the Southern Netherlands in 2002.

Authors:  V E P P Lemmens; C D G W Verheij; M L G Janssen-Heijnen; H J T Rutten; J W W Coebergh
Journal:  Eur J Surg Oncol       Date:  2006-01-04       Impact factor: 4.424

4.  Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.

Authors:  Mario Togni; Stephan Windecker; Rosangela Cocchia; Peter Wenaweser; Stephane Cook; Michael Billinger; Bernhard Meier; Otto M Hess
Journal:  J Am Coll Cardiol       Date:  2005-07-19       Impact factor: 24.094

5.  Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

Authors:  Andrew T L Ong; Ron T van Domburg; Jiro Aoki; Karel Sonnenschein; Pedro A Lemos; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2006-03-20       Impact factor: 24.094

6.  A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.

Authors:  Mohan N Babapulle; Lawrence Joseph; Patrick Bélisle; James M Brophy; Mark J Eisenberg
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

7.  Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.

Authors:  Pedro A Lemos; Patrick W Serruys; Ron T van Domburg; Francesco Saia; Chourmouzios A Arampatzis; Angela Hoye; Muzaffer Degertekin; Kengo Tanabe; Joost Daemen; Tommy K K Liu; Eugene McFadden; Georgios Sianos; Sjoerd H Hofma; Pieter C Smits; Willem J van der Giessen; Pim J de Feyter
Journal:  Circulation       Date:  2003-12-22       Impact factor: 29.690
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.